American Gene Technologies
Recent News About American Gene Technologies View More
-
AMERICAN GENE TECHNOLOGIES: John Trainer on NexImmune's Technology and the Rapid Growth of Biotech in Maryland
NexImmune’s unique approach to T cell technology
-
AMERICAN GENE TECHNOLOGIES: American Gene Technologies’ HIV Clinical Trial Demonstrates Blood Markers of Efficacy
Data from the First Three Patients Shows Critical Efficacy Markers of the HIV Cure Cell Therapy: Engraftment, Persistence, and Function of Infused Cells
-
AMERICAN GENE TECHNOLOGIES: American Gene Technologies Passes Major Milestone in Potential HIV Cure Clinical Trial with Third Patient Showing No Serious Adverse Effects (SAEs)
Announced that the independent Data Safety and Monitoring Board
-
AMERICAN GENE TECHNOLOGIES: Careers at Our Biotechnology Company
At AGT, you have the chance to be a part of a mission
-
AMERICAN GENE TECHNOLOGIES: American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO
American Gene Technologies (AGT) announces the appointment of Dr. Marcus A. Conant
-
AMERICAN GENE TECHNOLOGIES: American Gene Technologies Appoints Dr. Robert R. Redfield as Special Advisor to the CEO
Dr. Redfield’s expertise in virology strengthens AGT’s capacity to develop innovative HIV treatments.